Ziwei specialises in mRNA delivery, focusing on the design of precision nanotherapeutics for cancer immunotherapy.
Ziwei’s work aims to explore the potential of delivering mRNA to specific immune cells through the rational design of nanoparticles, improving therapeutic efficacy of mRNA in vaccines and cancer immunotherapy.
Ziwei obtained her Master’s degree in Pharmaceutics in 2024 and is currently pursuing a PhD under the supervision of Hao Song.